|
Pronunciation |
|
(in
doe SYE a neen
green) |
|
|
U.S. Brand
Names |
|
Cardio-Green® |
|
|
Generic
Available |
|
Yes |
|
|
Pharmacological Index |
|
Diagnostic Agent |
|
|
Use |
|
Determining hepatic function, cardiac output and liver blood flow and for
ophthalmic angiography |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Adverse
Reactions |
|
1% to 10%:
Dermatologic: Pruritus, skin discoloration
Miscellaneous: Sweating, anaphylactoid reactions |
|
|
Stability |
|
Reconstitute only with sterile water for injection supplied by
manufacturer |
|
|
Usual Dosage |
|
Angiography: Use 40 mg of dye in 2 mL of aqueous solvent, in some patients,
half the volume (1 mL) has been found to produce angiograms of comparable
resolution; immediately following the bolus dose of dye, a bolus of sodium
chloride 0.9% is given; this regimen will deliver a spatially limited dye bolus
of optimal concentration to the choroidal vasculature following I.V. injection
Determination of cardiac output: Dye is injected as rapidly as possible into
the right atrium, right ventricle, or pulmonary artery through a cardiac
catheter; the usual dose is 1.25 mg for infants, 2.5 mg for children, and 5 mg
for adults; total dose should not exceed 2 mg/kg; the dye is diluted with
sterile water for injection or sodium chloride 0.9% to make a final volume of 1
mL; doses are repeated periodically to obtain several dilution curves; the dye
should be flushed from the catheter with sodium chloride 0.9% to prevent
hemolysis |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Nursing
Implications |
|
Do not mix with preservative, bisulfite, metabisulfite, or borohydride
preparations |
|
|
Dosage Forms |
|
Injection: 25 mg, 50 mg |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|